nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—hematologic cancer—muscle cancer	0.747	1	CtDrD
Prednisone—SLCO1A2—Methotrexate—muscle cancer	0.0376	0.231	CbGbCtD
Prednisone—ABCB1—Dactinomycin—muscle cancer	0.0272	0.168	CbGbCtD
Prednisone—ALB—Methotrexate—muscle cancer	0.0194	0.119	CbGbCtD
Prednisone—ABCB1—Vincristine—muscle cancer	0.0168	0.103	CbGbCtD
Prednisone—ABCB1—Etoposide—muscle cancer	0.0154	0.0946	CbGbCtD
Prednisone—ABCB1—Doxorubicin—muscle cancer	0.0105	0.0645	CbGbCtD
Prednisone—ABCB1—Methotrexate—muscle cancer	0.0102	0.0625	CbGbCtD
Prednisone—CYP3A4—Vincristine—muscle cancer	0.0101	0.0618	CbGbCtD
Prednisone—CYP3A4—Etoposide—muscle cancer	0.00921	0.0567	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—muscle cancer	0.00628	0.0386	CbGbCtD
Prednisone—HSD11B1—smooth muscle tissue—muscle cancer	0.00154	0.129	CbGeAlD
Prednisone—HSD11B1—renal system—muscle cancer	0.00148	0.124	CbGeAlD
Prednisone—HSD11B1—tendon—muscle cancer	0.00115	0.0967	CbGeAlD
Prednisone—HSD11B1—vagina—muscle cancer	0.00107	0.0897	CbGeAlD
Prednisone—HSD11B1—head—muscle cancer	0.00099	0.0829	CbGeAlD
Prednisone—HSD11B1—testis—muscle cancer	0.000956	0.0801	CbGeAlD
Prednisone—SLCO1A2—renal system—muscle cancer	0.000448	0.0375	CbGeAlD
Prednisone—NR3C1—embryo—muscle cancer	0.00037	0.031	CbGeAlD
Prednisone—SLCO1A2—head—muscle cancer	0.000299	0.0251	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—muscle cancer	0.000291	0.0244	CbGeAlD
Prednisone—SLCO1A2—testis—muscle cancer	0.000289	0.0242	CbGeAlD
Prednisone—ALB—testis—muscle cancer	0.000288	0.0241	CbGeAlD
Prednisone—NR3C1—renal system—muscle cancer	0.00028	0.0234	CbGeAlD
Prednisone—CYP2C19—vagina—muscle cancer	0.000259	0.0217	CbGeAlD
Prednisone—NR3C1—cardiac atrium—muscle cancer	0.000251	0.021	CbGeAlD
Prednisone—Skin exfoliation—Methotrexate—muscle cancer	0.000224	0.00286	CcSEcCtD
Prednisone—Arthropathy—Doxorubicin—muscle cancer	0.000223	0.00285	CcSEcCtD
Prednisone—Angiopathy—Vincristine—muscle cancer	0.00022	0.00281	CcSEcCtD
Prednisone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000219	0.0028	CcSEcCtD
Prednisone—NR3C1—tendon—muscle cancer	0.000219	0.0183	CbGeAlD
Prednisone—Anaemia—Dactinomycin—muscle cancer	0.000218	0.00279	CcSEcCtD
Prednisone—Acute coronary syndrome—Etoposide—muscle cancer	0.000216	0.00276	CcSEcCtD
Prednisone—Ulcer—Doxorubicin—muscle cancer	0.000214	0.00274	CcSEcCtD
Prednisone—Neuropathy peripheral—Etoposide—muscle cancer	0.000214	0.00274	CcSEcCtD
Prednisone—Myocardial infarction—Etoposide—muscle cancer	0.000214	0.00274	CcSEcCtD
Prednisone—Alopecia—Vincristine—muscle cancer	0.000214	0.00274	CcSEcCtD
Prednisone—Malaise—Dactinomycin—muscle cancer	0.000213	0.00272	CcSEcCtD
Prednisone—Mental disorder—Vincristine—muscle cancer	0.000212	0.00272	CcSEcCtD
Prednisone—CYP3A4—renal system—muscle cancer	0.000212	0.0177	CbGeAlD
Prednisone—NR3C1—bone marrow—muscle cancer	0.000212	0.0177	CbGeAlD
Prednisone—Ecchymosis—Methotrexate—muscle cancer	0.000212	0.00271	CcSEcCtD
Prednisone—Pulmonary oedema—Methotrexate—muscle cancer	0.000208	0.00267	CcSEcCtD
Prednisone—Sepsis—Methotrexate—muscle cancer	0.000203	0.0026	CcSEcCtD
Prednisone—NR3C1—vagina—muscle cancer	0.000203	0.017	CbGeAlD
Prednisone—Hiccups—Doxorubicin—muscle cancer	0.000203	0.00259	CcSEcCtD
Prednisone—Myalgia—Dactinomycin—muscle cancer	0.000201	0.00257	CcSEcCtD
Prednisone—Discomfort—Dactinomycin—muscle cancer	0.000199	0.00254	CcSEcCtD
Prednisone—ABCB1—embryo—muscle cancer	0.000198	0.0166	CbGeAlD
Prednisone—Thrombophlebitis—Methotrexate—muscle cancer	0.000196	0.00251	CcSEcCtD
Prednisone—Diabetes mellitus—Methotrexate—muscle cancer	0.000195	0.0025	CcSEcCtD
Prednisone—Anaemia—Vincristine—muscle cancer	0.000195	0.00249	CcSEcCtD
Prednisone—Agitation—Vincristine—muscle cancer	0.000194	0.00248	CcSEcCtD
Prednisone—Skin exfoliation—Doxorubicin—muscle cancer	0.000194	0.00248	CcSEcCtD
Prednisone—Oedema—Dactinomycin—muscle cancer	0.000193	0.00246	CcSEcCtD
Prednisone—Fluid retention—Doxorubicin—muscle cancer	0.000192	0.00246	CcSEcCtD
Prednisone—Infection—Dactinomycin—muscle cancer	0.000191	0.00245	CcSEcCtD
Prednisone—Neuropathy—Doxorubicin—muscle cancer	0.00019	0.00243	CcSEcCtD
Prednisone—Vertigo—Vincristine—muscle cancer	0.00019	0.00242	CcSEcCtD
Prednisone—NR3C1—head—muscle cancer	0.000187	0.0157	CbGeAlD
Prednisone—Oesophagitis—Doxorubicin—muscle cancer	0.000185	0.00237	CcSEcCtD
Prednisone—Anorexia—Dactinomycin—muscle cancer	0.000184	0.00235	CcSEcCtD
Prednisone—Eye disorder—Etoposide—muscle cancer	0.000183	0.00235	CcSEcCtD
Prednisone—Ecchymosis—Doxorubicin—muscle cancer	0.000183	0.00234	CcSEcCtD
Prednisone—Convulsion—Vincristine—muscle cancer	0.000183	0.00234	CcSEcCtD
Prednisone—Flushing—Etoposide—muscle cancer	0.000182	0.00233	CcSEcCtD
Prednisone—Hypertension—Vincristine—muscle cancer	0.000182	0.00233	CcSEcCtD
Prednisone—NR3C1—testis—muscle cancer	0.000181	0.0152	CbGeAlD
Prednisone—Pulmonary oedema—Doxorubicin—muscle cancer	0.00018	0.00231	CcSEcCtD
Prednisone—Myalgia—Vincristine—muscle cancer	0.00018	0.0023	CcSEcCtD
Prednisone—Angiopathy—Etoposide—muscle cancer	0.000178	0.00228	CcSEcCtD
Prednisone—Immune system disorder—Etoposide—muscle cancer	0.000177	0.00227	CcSEcCtD
Prednisone—Sepsis—Doxorubicin—muscle cancer	0.000176	0.00225	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000176	0.00225	CcSEcCtD
Prednisone—Alopecia—Etoposide—muscle cancer	0.000173	0.00222	CcSEcCtD
Prednisone—Lethargy—Methotrexate—muscle cancer	0.000173	0.00222	CcSEcCtD
Prednisone—Anaphylactic shock—Vincristine—muscle cancer	0.000172	0.0022	CcSEcCtD
Prednisone—Oedema—Vincristine—muscle cancer	0.000172	0.0022	CcSEcCtD
Prednisone—Infection—Vincristine—muscle cancer	0.000171	0.00219	CcSEcCtD
Prednisone—Thrombophlebitis—Doxorubicin—muscle cancer	0.00017	0.00217	CcSEcCtD
Prednisone—Osteoarthritis—Methotrexate—muscle cancer	0.00017	0.00217	CcSEcCtD
Prednisone—Diabetes mellitus—Doxorubicin—muscle cancer	0.000169	0.00216	CcSEcCtD
Prednisone—Nervous system disorder—Vincristine—muscle cancer	0.000169	0.00216	CcSEcCtD
Prednisone—Decreased appetite—Dactinomycin—muscle cancer	0.000168	0.00214	CcSEcCtD
Prednisone—Hyperhidrosis—Vincristine—muscle cancer	0.000166	0.00213	CcSEcCtD
Prednisone—Fatigue—Dactinomycin—muscle cancer	0.000166	0.00212	CcSEcCtD
Prednisone—Vascular purpura—Doxorubicin—muscle cancer	0.000165	0.0021	CcSEcCtD
Prednisone—Anorexia—Vincristine—muscle cancer	0.000164	0.0021	CcSEcCtD
Prednisone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000162	0.00208	CcSEcCtD
Prednisone—Irritability—Methotrexate—muscle cancer	0.000162	0.00207	CcSEcCtD
Prednisone—Mood swings—Methotrexate—muscle cancer	0.000161	0.00206	CcSEcCtD
Prednisone—Feeling abnormal—Dactinomycin—muscle cancer	0.000159	0.00203	CcSEcCtD
Prednisone—Ill-defined disorder—Etoposide—muscle cancer	0.000159	0.00203	CcSEcCtD
Prednisone—Anaemia—Etoposide—muscle cancer	0.000158	0.00202	CcSEcCtD
Prednisone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000158	0.00202	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000157	0.00201	CcSEcCtD
Prednisone—Increased appetite—Doxorubicin—muscle cancer	0.000157	0.002	CcSEcCtD
Prednisone—Insomnia—Vincristine—muscle cancer	0.000156	0.00199	CcSEcCtD
Prednisone—Paraesthesia—Vincristine—muscle cancer	0.000155	0.00198	CcSEcCtD
Prednisone—Malaise—Etoposide—muscle cancer	0.000154	0.00197	CcSEcCtD
Prednisone—Vertigo—Etoposide—muscle cancer	0.000154	0.00196	CcSEcCtD
Prednisone—Purpura—Doxorubicin—muscle cancer	0.000153	0.00195	CcSEcCtD
Prednisone—Abdominal pain—Dactinomycin—muscle cancer	0.000152	0.00195	CcSEcCtD
Prednisone—Body temperature increased—Dactinomycin—muscle cancer	0.000152	0.00195	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—muscle cancer	0.000151	0.00193	CcSEcCtD
Prednisone—Loss of consciousness—Etoposide—muscle cancer	0.00015	0.00192	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—muscle cancer	0.00015	0.00192	CcSEcCtD
Prednisone—ABCB1—renal system—muscle cancer	0.00015	0.0126	CbGeAlD
Prednisone—Decreased appetite—Vincristine—muscle cancer	0.00015	0.00191	CcSEcCtD
Prednisone—Fatigue—Vincristine—muscle cancer	0.000148	0.0019	CcSEcCtD
Prednisone—Convulsion—Etoposide—muscle cancer	0.000148	0.00189	CcSEcCtD
Prednisone—Hypertension—Etoposide—muscle cancer	0.000148	0.00189	CcSEcCtD
Prednisone—Constipation—Vincristine—muscle cancer	0.000147	0.00188	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—muscle cancer	0.000147	0.00188	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000147	0.00188	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—muscle cancer	0.000145	0.00185	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000144	0.00185	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—muscle cancer	0.000144	0.00184	CcSEcCtD
Prednisone—Discomfort—Etoposide—muscle cancer	0.000144	0.00184	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—muscle cancer	0.000142	0.00182	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—muscle cancer	0.000142	0.00182	CcSEcCtD
Prednisone—Gastrointestinal pain—Vincristine—muscle cancer	0.000141	0.0018	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—muscle cancer	0.00014	0.00179	CcSEcCtD
Prednisone—Anaphylactic shock—Etoposide—muscle cancer	0.000139	0.00178	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—muscle cancer	0.000139	0.00178	CcSEcCtD
Prednisone—Infection—Etoposide—muscle cancer	0.000139	0.00177	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—muscle cancer	0.000138	0.00177	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—muscle cancer	0.000137	0.00176	CcSEcCtD
Prednisone—Tachycardia—Etoposide—muscle cancer	0.000136	0.00174	CcSEcCtD
Prednisone—Body temperature increased—Vincristine—muscle cancer	0.000136	0.00174	CcSEcCtD
Prednisone—Abdominal pain—Vincristine—muscle cancer	0.000136	0.00174	CcSEcCtD
Prednisone—Skin disorder—Etoposide—muscle cancer	0.000135	0.00173	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—muscle cancer	0.000135	0.00173	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—muscle cancer	0.000135	0.00173	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—muscle cancer	0.000135	0.00172	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—muscle cancer	0.000134	0.00171	CcSEcCtD
Prednisone—Anorexia—Etoposide—muscle cancer	0.000133	0.0017	CcSEcCtD
Prednisone—Diarrhoea—Dactinomycin—muscle cancer	0.000132	0.00169	CcSEcCtD
Prednisone—Depression—Methotrexate—muscle cancer	0.000131	0.00167	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00013	0.00166	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—muscle cancer	0.00013	0.00166	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—muscle cancer	0.000128	0.00164	CcSEcCtD
Prednisone—Hypersensitivity—Vincristine—muscle cancer	0.000127	0.00162	CcSEcCtD
Prednisone—Paraesthesia—Etoposide—muscle cancer	0.000125	0.0016	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—muscle cancer	0.000125	0.0016	CcSEcCtD
Prednisone—Asthenia—Vincristine—muscle cancer	0.000124	0.00158	CcSEcCtD
Prednisone—Vomiting—Dactinomycin—muscle cancer	0.000123	0.00157	CcSEcCtD
Prednisone—Rash—Dactinomycin—muscle cancer	0.000122	0.00155	CcSEcCtD
Prednisone—Decreased appetite—Etoposide—muscle cancer	0.000121	0.00155	CcSEcCtD
Prednisone—Fatigue—Etoposide—muscle cancer	0.00012	0.00154	CcSEcCtD
Prednisone—Constipation—Etoposide—muscle cancer	0.000119	0.00153	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—muscle cancer	0.000119	0.00152	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—muscle cancer	0.000118	0.00151	CcSEcCtD
Prednisone—Diarrhoea—Vincristine—muscle cancer	0.000118	0.00151	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—muscle cancer	0.000118	0.0015	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—muscle cancer	0.000116	0.00148	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—muscle cancer	0.000115	0.00147	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—muscle cancer	0.000115	0.00147	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—muscle cancer	0.000115	0.00147	CcSEcCtD
Prednisone—Nausea—Dactinomycin—muscle cancer	0.000114	0.00146	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—muscle cancer	0.000114	0.00146	CcSEcCtD
Prednisone—Dizziness—Vincristine—muscle cancer	0.000114	0.00146	CcSEcCtD
Prednisone—ABCB1—bone marrow—muscle cancer	0.000113	0.00949	CbGeAlD
Prednisone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000111	0.00142	CcSEcCtD
Prednisone—Urticaria—Etoposide—muscle cancer	0.000111	0.00142	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—muscle cancer	0.00011	0.00141	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—muscle cancer	0.00011	0.00141	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—muscle cancer	0.00011	0.00141	CcSEcCtD
Prednisone—Vomiting—Vincristine—muscle cancer	0.000109	0.0014	CcSEcCtD
Prednisone—ABCB1—vagina—muscle cancer	0.000109	0.00909	CbGeAlD
Prednisone—Rash—Vincristine—muscle cancer	0.000109	0.00139	CcSEcCtD
Prednisone—Dermatitis—Vincristine—muscle cancer	0.000108	0.00139	CcSEcCtD
Prednisone—Headache—Vincristine—muscle cancer	0.000108	0.00138	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—muscle cancer	0.000107	0.00136	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—muscle cancer	0.000106	0.00136	CcSEcCtD
Prednisone—Alopecia—Methotrexate—muscle cancer	0.000104	0.00133	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—muscle cancer	0.000104	0.00133	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—muscle cancer	0.000103	0.00132	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—muscle cancer	0.000103	0.00131	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—muscle cancer	0.000102	0.00131	CcSEcCtD
Prednisone—Erythema—Methotrexate—muscle cancer	0.000102	0.00131	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—muscle cancer	0.000102	0.00131	CcSEcCtD
Prednisone—Nausea—Vincristine—muscle cancer	0.000102	0.00131	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—muscle cancer	0.000102	0.0013	CcSEcCtD
Prednisone—ABCB1—head—muscle cancer	0.0001	0.0084	CbGeAlD
Prednisone—Asthenia—Etoposide—muscle cancer	0.0001	0.00128	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—muscle cancer	0.0001	0.00128	CcSEcCtD
Prednisone—Pruritus—Etoposide—muscle cancer	9.87e-05	0.00126	CcSEcCtD
Prednisone—ABCB1—testis—muscle cancer	9.69e-05	0.00811	CbGeAlD
Prednisone—Vision blurred—Methotrexate—muscle cancer	9.65e-05	0.00123	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—muscle cancer	9.54e-05	0.00122	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—muscle cancer	9.52e-05	0.00122	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—muscle cancer	9.5e-05	0.00121	CcSEcCtD
Prednisone—Anaemia—Methotrexate—muscle cancer	9.46e-05	0.00121	CcSEcCtD
Prednisone—Flushing—Doxorubicin—muscle cancer	9.45e-05	0.00121	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—muscle cancer	9.24e-05	0.00118	CcSEcCtD
Prednisone—Malaise—Methotrexate—muscle cancer	9.23e-05	0.00118	CcSEcCtD
Prednisone—Dizziness—Etoposide—muscle cancer	9.22e-05	0.00118	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—muscle cancer	9.2e-05	0.00118	CcSEcCtD
Prednisone—Vertigo—Methotrexate—muscle cancer	9.2e-05	0.00118	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—muscle cancer	9.1e-05	0.00116	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—muscle cancer	9e-05	0.00115	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—muscle cancer	8.92e-05	0.00114	CcSEcCtD
Prednisone—Convulsion—Methotrexate—muscle cancer	8.87e-05	0.00113	CcSEcCtD
Prednisone—Vomiting—Etoposide—muscle cancer	8.87e-05	0.00113	CcSEcCtD
Prednisone—Erythema—Doxorubicin—muscle cancer	8.86e-05	0.00113	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—muscle cancer	8.86e-05	0.00113	CcSEcCtD
Prednisone—Rash—Etoposide—muscle cancer	8.79e-05	0.00112	CcSEcCtD
Prednisone—Dermatitis—Etoposide—muscle cancer	8.79e-05	0.00112	CcSEcCtD
Prednisone—Headache—Etoposide—muscle cancer	8.74e-05	0.00112	CcSEcCtD
Prednisone—Myalgia—Methotrexate—muscle cancer	8.71e-05	0.00111	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—muscle cancer	8.71e-05	0.00111	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.65e-05	0.00111	CcSEcCtD
Prednisone—Discomfort—Methotrexate—muscle cancer	8.61e-05	0.0011	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—muscle cancer	8.35e-05	0.00107	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—muscle cancer	8.35e-05	0.00107	CcSEcCtD
Prednisone—Infection—Methotrexate—muscle cancer	8.3e-05	0.00106	CcSEcCtD
Prednisone—Nausea—Etoposide—muscle cancer	8.28e-05	0.00106	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—muscle cancer	8.22e-05	0.00105	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—muscle cancer	8.19e-05	0.00105	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—muscle cancer	8.19e-05	0.00105	CcSEcCtD
Prednisone—Agitation—Doxorubicin—muscle cancer	8.15e-05	0.00104	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—muscle cancer	8.11e-05	0.00104	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—muscle cancer	8.08e-05	0.00103	CcSEcCtD
Prednisone—Malaise—Doxorubicin—muscle cancer	7.99e-05	0.00102	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—muscle cancer	7.96e-05	0.00102	CcSEcCtD
Prednisone—Anorexia—Methotrexate—muscle cancer	7.96e-05	0.00102	CcSEcCtD
Prednisone—Syncope—Doxorubicin—muscle cancer	7.95e-05	0.00102	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—muscle cancer	7.79e-05	0.000996	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—muscle cancer	7.68e-05	0.000982	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—muscle cancer	7.65e-05	0.000979	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.61e-05	0.000973	CcSEcCtD
Prednisone—Insomnia—Methotrexate—muscle cancer	7.56e-05	0.000966	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—muscle cancer	7.55e-05	0.000965	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—muscle cancer	7.55e-05	0.000965	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—muscle cancer	7.52e-05	0.000962	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—muscle cancer	7.5e-05	0.000959	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.49e-05	0.000958	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—muscle cancer	7.46e-05	0.000954	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—muscle cancer	7.35e-05	0.00094	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—muscle cancer	7.26e-05	0.000929	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—muscle cancer	7.23e-05	0.000925	CcSEcCtD
Prednisone—Oedema—Doxorubicin—muscle cancer	7.23e-05	0.000925	CcSEcCtD
Prednisone—Fatigue—Methotrexate—muscle cancer	7.2e-05	0.000921	CcSEcCtD
Prednisone—Infection—Doxorubicin—muscle cancer	7.19e-05	0.000919	CcSEcCtD
Prednisone—Shock—Doxorubicin—muscle cancer	7.12e-05	0.00091	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—muscle cancer	7.09e-05	0.000907	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—muscle cancer	7.06e-05	0.000903	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—muscle cancer	7.03e-05	0.000899	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—muscle cancer	6.99e-05	0.000894	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—muscle cancer	6.9e-05	0.000882	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—muscle cancer	6.88e-05	0.00088	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—muscle cancer	6.83e-05	0.000874	CcSEcCtD
Prednisone—Urticaria—Methotrexate—muscle cancer	6.64e-05	0.000849	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—muscle cancer	6.6e-05	0.000845	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—muscle cancer	6.6e-05	0.000845	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.59e-05	0.000843	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—muscle cancer	6.54e-05	0.000837	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—muscle cancer	6.5e-05	0.000831	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—muscle cancer	6.37e-05	0.000814	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—muscle cancer	6.29e-05	0.000804	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—muscle cancer	6.24e-05	0.000798	CcSEcCtD
Prednisone—Constipation—Doxorubicin—muscle cancer	6.19e-05	0.000791	CcSEcCtD
Prednisone—Hypersensitivity—Methotrexate—muscle cancer	6.16e-05	0.000787	CcSEcCtD
Prednisone—Asthenia—Methotrexate—muscle cancer	5.99e-05	0.000767	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—muscle cancer	5.96e-05	0.000762	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—muscle cancer	5.92e-05	0.000757	CcSEcCtD
Prednisone—Pruritus—Methotrexate—muscle cancer	5.91e-05	0.000756	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—muscle cancer	5.75e-05	0.000735	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—muscle cancer	5.72e-05	0.000731	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—muscle cancer	5.72e-05	0.000731	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—muscle cancer	5.72e-05	0.000731	CcSEcCtD
Prednisone—Dizziness—Methotrexate—muscle cancer	5.52e-05	0.000707	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—muscle cancer	5.33e-05	0.000682	CcSEcCtD
Prednisone—Vomiting—Methotrexate—muscle cancer	5.31e-05	0.000679	CcSEcCtD
Prednisone—Rash—Methotrexate—muscle cancer	5.27e-05	0.000674	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—muscle cancer	5.26e-05	0.000673	CcSEcCtD
Prednisone—Headache—Methotrexate—muscle cancer	5.23e-05	0.000669	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—muscle cancer	5.19e-05	0.000664	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—muscle cancer	5.12e-05	0.000655	CcSEcCtD
Prednisone—Nausea—Methotrexate—muscle cancer	4.96e-05	0.000635	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—muscle cancer	4.95e-05	0.000633	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—muscle cancer	4.78e-05	0.000612	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—muscle cancer	4.6e-05	0.000588	CcSEcCtD
Prednisone—Rash—Doxorubicin—muscle cancer	4.56e-05	0.000583	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—muscle cancer	4.56e-05	0.000583	CcSEcCtD
Prednisone—Headache—Doxorubicin—muscle cancer	4.53e-05	0.00058	CcSEcCtD
Prednisone—Nausea—Doxorubicin—muscle cancer	4.3e-05	0.00055	CcSEcCtD
